Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,867 | 8,845 | 8,667 | 13,985 | 7,827 |
| Other current assets | 0 | 0 | 18 | 18 | 18 |
| TOTAL | $5,240 | $10,178 | $9,327 | $14,228 | $8,198 |
| Non-Current Assets | |||||
| PPE Net | 908 | 967 | 814 | 824 | 772 |
| Other Non-Current Assets | 2,596 | 2,762 | 1,285 | 1,393 | 1,499 |
| TOTAL | $3,504 | $3,729 | $2,099 | $2,217 | $2,271 |
| Total Assets | $8,744 | $13,907 | $11,426 | $16,445 | $10,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,573 | 8,066 | N/A | 9,168 | N/A |
| Accounts payable and accrued liabilities | 1,069 | 1,801 | 1,417 | 2,697 | 3,042 |
| Other current liabilities | 437 | 470 | 543 | 460 | 3,128 |
| TOTAL | $6,722 | $10,964 | $8,211 | $12,726 | $6,677 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,897 | 2,083 | 865 | 984 | 1,055 |
| TOTAL | $1,897 | $2,083 | $865 | $984 | $1,055 |
| Total Liabilities | $8,619 | $13,047 | $9,076 | $13,710 | $7,732 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,456 | 41,889 | 38,263 | 37,735 | 34,659 |
| Retained earnings | -50,920 | -45,142 | -40,484 | -35,518 | -32,419 |
| TOTAL | $125 | $860 | $2,350 | $2,735 | $2,737 |
| Total Liabilities And Equity | $8,744 | $13,907 | $11,426 | $16,445 | $10,469 |